Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.

A number of chemical compounds have been shown to induce liver tumors in mice but not in other species. While several mechanisms for this species-specific tumorigenicity have been proposed, no definitive mechanism has been established. We examined the effects of the nongenotoxic rodent hepatic carci...

Full description

Bibliographic Details
Main Authors: Timothy M Coskran, Zhijie Jiang, James E Klaunig, Dixie L Mager, Leslie Obert, Andrew Robertson, Nicholas Tsinoremas, Zemin Wang, Mark Gosink
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5417610?pdf=render
_version_ 1818324116755709952
author Timothy M Coskran
Zhijie Jiang
James E Klaunig
Dixie L Mager
Leslie Obert
Andrew Robertson
Nicholas Tsinoremas
Zemin Wang
Mark Gosink
author_facet Timothy M Coskran
Zhijie Jiang
James E Klaunig
Dixie L Mager
Leslie Obert
Andrew Robertson
Nicholas Tsinoremas
Zemin Wang
Mark Gosink
author_sort Timothy M Coskran
collection DOAJ
description A number of chemical compounds have been shown to induce liver tumors in mice but not in other species. While several mechanisms for this species-specific tumorigenicity have been proposed, no definitive mechanism has been established. We examined the effects of the nongenotoxic rodent hepatic carcinogen, WY-14,643, in male mice from a high liver tumor susceptible strain (C3H/HeJ), and from a low tumor susceptible strain (C57BL/6). WY-14,643, a PPARα activator induced widespread increases in the expression of some endogenous retroelements, namely members of LTR and LINE elements in both strains. The expression of a number of known retroviral defense genes was also elevated. We also demonstrated that basal immune-mediated viral defense was elevated in C57BL/6 mice (the resistant strain) and that WY-14,643 further activated those immuno-defense processes. We propose that the previously reported >100X activity of retroelements in mice drives mouse-specific tumorigenicity. We also propose that C57BL/6's competent immune to retroviral activation allows it to remove cells before the activation of these elements can result in significant chromosomal insertions and mutation. Finally, we showed that WY-14,643 treatment induced gene signatures of DNA recombination in the sensitive C3H/HeJ strain.
first_indexed 2024-12-13T11:23:29Z
format Article
id doaj.art-77f70d26f5cc49d79b7be814cb53e00a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T11:23:29Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-77f70d26f5cc49d79b7be814cb53e00a2022-12-21T23:48:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01125e017676810.1371/journal.pone.0176768Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.Timothy M CoskranZhijie JiangJames E KlaunigDixie L MagerLeslie ObertAndrew RobertsonNicholas TsinoremasZemin WangMark GosinkA number of chemical compounds have been shown to induce liver tumors in mice but not in other species. While several mechanisms for this species-specific tumorigenicity have been proposed, no definitive mechanism has been established. We examined the effects of the nongenotoxic rodent hepatic carcinogen, WY-14,643, in male mice from a high liver tumor susceptible strain (C3H/HeJ), and from a low tumor susceptible strain (C57BL/6). WY-14,643, a PPARα activator induced widespread increases in the expression of some endogenous retroelements, namely members of LTR and LINE elements in both strains. The expression of a number of known retroviral defense genes was also elevated. We also demonstrated that basal immune-mediated viral defense was elevated in C57BL/6 mice (the resistant strain) and that WY-14,643 further activated those immuno-defense processes. We propose that the previously reported >100X activity of retroelements in mice drives mouse-specific tumorigenicity. We also propose that C57BL/6's competent immune to retroviral activation allows it to remove cells before the activation of these elements can result in significant chromosomal insertions and mutation. Finally, we showed that WY-14,643 treatment induced gene signatures of DNA recombination in the sensitive C3H/HeJ strain.http://europepmc.org/articles/PMC5417610?pdf=render
spellingShingle Timothy M Coskran
Zhijie Jiang
James E Klaunig
Dixie L Mager
Leslie Obert
Andrew Robertson
Nicholas Tsinoremas
Zemin Wang
Mark Gosink
Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.
PLoS ONE
title Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.
title_full Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.
title_fullStr Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.
title_full_unstemmed Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.
title_short Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.
title_sort induction of endogenous retroelements as a potential mechanism for mouse specific drug induced carcinogenicity
url http://europepmc.org/articles/PMC5417610?pdf=render
work_keys_str_mv AT timothymcoskran inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity
AT zhijiejiang inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity
AT jameseklaunig inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity
AT dixielmager inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity
AT leslieobert inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity
AT andrewrobertson inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity
AT nicholastsinoremas inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity
AT zeminwang inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity
AT markgosink inductionofendogenousretroelementsasapotentialmechanismformousespecificdruginducedcarcinogenicity